Trevi Therapeutics, Inc. (TRVI) Q4 2025 Earnings Results
Earnings Per Share (GAAP) $-0.06 vs $-0.10 est. (narrower loss, 37.2%) Loss narrows sharply. Trevi Therapeutics, Inc. (NASDAQ: TRVI) reported ...
Monday, September 21, 2026
Tag: TRVI
Get the latest news and follow the coverage of Business & Financial News, Stock Market Updates, Analysis, and more from the trusted sources.